Manayon, Zyque S.
HRN: 21-91-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
COTRIMOXAZOLE 960MG (TAB)
09/14/2022
09/20/2022
PO
960mg
OD
Immunocompromised State (PCP)
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes